Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12414776 | 0.78 | KDM4E (0.36) | GABRA1GABRB2 | |
| SCHEMBL24666920 | 0.77 | ACHE (0.32) | GABRA1GABRB2 | |
| SCHEMBL24873411 | 0.77 | HTT (0.31) | GABRA1GABRB2 | |
| SCHEMBL22572506 | 0.77 | — | — | |
| SCHEMBL23400877 | 0.76 | GABRA1 (0.41) | GABRA1GABRB2 | |
| SCHEMBL29338016 | 0.69 | GAA (0.32) | — | |
| SCHEMBL22724157 | 0.69 | DRD3 (0.35) | — | |
| SCHEMBL21258471 | 0.68 | KAT2B (0.31) | — | |
| SCHEMBL22723977 | 0.68 | ICMT (0.35) | — | |
| SCHEMBL20843901 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158025-A1 | GALACTOKINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH | 2023-05-25 | — | — | US | disclosed |
| US-20230158025-A1 | GALACTOKINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158025-A1 | GALACTOKINASE INHIBITORS | GALK1, GCK, GCKR | GABRA1 3946/4885GABRB2 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.